Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (27)

2022

  1. Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands

    Biomedicine and Pharmacotherapy, Vol. 153

2021

  1. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2020

  1. Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity

    Scientific Reports, Vol. 10, Núm. 1

  2. Essential role of the C148–C227 disulphide bridge in the human 5-HT2A homodimeric receptor

    Biochemical Pharmacology, Vol. 177

2019

  1. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia

    EBioMedicine, Vol. 39, pp. 118-131

  2. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401

2018

  1. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke

    Annals of Neurology, Vol. 84, Núm. 2, pp. 260-273

2017

  1. The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8)on the surface of SH-SY5Y cells

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. 2D-DIGE-based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site

    Proteomics - Clinical Applications, Vol. 10, Núm. 8, pp. 851-858

  2. A novel mechanism of neuroprotection: Blood glutamate grabber

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 2, pp. 292-301

  3. Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches

    Scientific Reports, Vol. 6

  4. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestins

    Scientific Reports, Vol. 6

  5. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy

    Journal of Proteomics, Vol. 148, pp. 75-84

2015

  1. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

2014

  1. Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 716-726

  2. Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: Its downregulation by DISC1

    Human Molecular Genetics, Vol. 23, Núm. 22, pp. 5859-5865

2013

  1. Erratum: Nucleofection of whole murine retinas (Cytotechnology DOI: 10.1007/s10616-012-9509-3)

    Cytotechnology

2012

  1. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: Implications for CLEC-2 signaling regulation

    Blood, Vol. 120, Núm. 26

  2. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

    Oncogene, Vol. 31, Núm. 45, pp. 4778-4788

2011

  1. Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells

    Cellular Immunology, Vol. 271, Núm. 2, pp. 319-328